GE HealthCare Technologies (NASDAQ:GEHC) Downgraded to Strong Sell Rating by Zacks Research

Zacks Research downgraded shares of GE HealthCare Technologies (NASDAQ:GEHC) from a hold rating to a strong sell rating in a report issued on Tuesday,Zacks.com reports.

Other research analysts also recently issued reports about the company. Wells Fargo & Company reduced their target price on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Barclays decreased their price objective on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a research note on Thursday, April 30th. BNP Paribas Exane lowered their price target on GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. BTIG Research reissued a “buy” rating and set a $75.00 price objective on shares of GE HealthCare Technologies in a research note on Monday, July 13th. Finally, The Goldman Sachs Group restated a “neutral” rating on shares of GE HealthCare Technologies in a report on Monday, June 8th. Ten analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Hold” and an average target price of $76.41.

GE HealthCare Technologies Stock Down 1.0%

GEHC opened at $61.41 on Tuesday. GE HealthCare Technologies has a twelve month low of $58.75 and a twelve month high of $89.77. The business has a 50 day moving average price of $63.65 and a 200 day moving average price of $71.46. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The firm has a market cap of $27.93 billion, a P/E ratio of 14.69, a price-to-earnings-growth ratio of 1.69 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts forecast that GE HealthCare Technologies will post 4.89 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.35%.

Insiders Place Their Bets

In related news, CEO Peter J. Arduini bought 4,169 shares of GE HealthCare Technologies stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average cost of $59.92 per share, with a total value of $249,806.48. Following the purchase, the chief executive officer owned 259,424 shares in the company, valued at approximately $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kevin Lobo purchased 10,000 shares of the company’s stock in a transaction on Friday, May 22nd. The stock was purchased at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the purchase, the director directly owned 14,363 shares in the company, valued at approximately $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 21,847 shares of company stock worth $1,361,355 in the last ninety days. 0.36% of the stock is owned by insiders.

Hedge Funds Weigh In On GE HealthCare Technologies

Several hedge funds have recently made changes to their positions in the business. Banque Cantonale Vaudoise lifted its position in shares of GE HealthCare Technologies by 16,539.1% during the 1st quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock valued at $1,849,000 after acquiring an additional 25,801 shares during the period. Allstate Corp raised its position in shares of GE HealthCare Technologies by 100.3% during the fourth quarter. Allstate Corp now owns 32,688 shares of the company’s stock worth $2,681,000 after purchasing an additional 16,365 shares during the period. Perpetual Ltd acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at $37,656,000. Herbst Group LLC bought a new stake in GE HealthCare Technologies during the 4th quarter valued at $2,276,000. Finally, Auto Owners Insurance Co raised its holdings in GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after buying an additional 33,629,559 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.